Management of atrial fibrillation

Nov 13, 2017

New Study Consistent with Trial Results for Dabigatran and Warfarin in Atrial Fibrillation

Nov 02, 2017

Cardiome Announces Expansion of Global Geographic Footprint for Brinavess®

Nov 02, 2017

Five-year Follow-up Data Demonstrate the WATCHMAN(TM) Left Atrial Appendage Closure Device Provides Stroke Risk Reduction Comparable to Warfarin Therapy

Aug 30, 2017

New Data Presented at European Society of Cardiology Congress 2017 Highlights Clinical Benefit of BRINAVESS®

Aug 29, 2017

New Sub-analysis Data Highlights the Benefit of LIXIANA(R) (edoxaban) Over Warfarin in NVAF Patients According to More Comprehensive Stroke Risk Scoring

Aug 22, 2017

Landmark GARFIELD-AF Data to be Presented at ESC 2017 Congress Will Feature 1-year Outcomes on 52,000 Prospective Patients and the First Insights From the Registry on Health Economics in Atrial Fibrillation (AF)

Aug 21, 2017

Cardiome Provides U.S. Regulatory Update For BRINAVESS

Jun 12, 2017

Cardiome Announces Commercial Launch of BRINAVESS® (Vernakalant Hydrochloride) in Canada